SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-683513
Filing Date
2016-08-17
Accepted
2016-08-17 06:09:03
Documents
7
Period of Report
2016-08-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d229221d8k.htm 8-K 19287
2 EX-1.1 d229221dex11.htm EX-1.1 173257
3 EX-5.1 d229221dex51.htm EX-5.1 8576
4 EX-99.1 d229221dex991.htm EX-99.1 9797
5 EX-99.2 d229221dex992.htm EX-99.2 9971
6 GRAPHIC g229221dsp046.jpg GRAPHIC 16193
7 GRAPHIC g229221dsp48.jpg GRAPHIC 4918
  Complete submission text file 0001193125-16-683513.txt   245724
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36329 | Film No.: 161837428
SIC: 2834 Pharmaceutical Preparations